- Would you restart rituximab as part of a new chemotherapy regimen for this patient with DLBCL?
Thursday, December 1st, 2016
This month, Arnold S. Freedman, MD, answers a question about restarting rituximab as part of a new chemotherapy regimen for a patient with diffuse large B-cell lymphoma. Clinical Dilemma: In 2012, I treated a young man with follicular lymphoma with four cycles of bendamustine/rituximab. He developed prolonged neutropenia (presumed rituximab associated) that lasted eight months. [...]